News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Intravesical pembrolizumab delivers antitumour activity in NMIBC
08 Sep 2022
byTristan Manalac
A recent first-in-human study has shown that directly applying pembrolizumab to the bladder is a safe and effective treatment option for patients with nonmuscle-invasive bladder cancer (NMIBC) who are unresponsive to bacillus Calmette-Guérin (BCG) treatment.
08 Sep 2022







